DOI: 10.1515/jpem-2026-0064 ISSN: 0334-018X

Larks vs. owls: exploring chronotype, glycaemic control, and quality of life in paediatric type 1 diabetes

Dilek Bingöl Aydın, Berivan Uruç, Engin Aydın, Fatma Özgüç Çömlek, Yavuz Özer

Abstract

Objectives

Chronotype reflects individual circadian preferences and may influence metabolic regulation and daily functioning. This study aimed to investigate the association between chronotype and glycaemic control, assessed by HbA 1c , as well as health-related quality of life in children and adolescents with type 1 diabetes mellitus.

Methods

This cross-sectional study included 84 children and adolescents aged 8–18 years with type 1 diabetes of at least one year’s duration. Chronotype was assessed using the Munich Chronotype Questionnaire. Health-related quality of life was evaluated using age-appropriate versions of the Pediatric Quality of Life Inventory (PedsQL™). Glycaemic control was assessed using the mean HbA 1c value from the most recent three months.

Results

Chronotype distribution was 19.0 % morning, 44.0 % intermediate, and 36.9 % evening. HbA 1c levels differed significantly among chronotype groups (p=0.003), with higher levels observed in participants with an evening chronotype compared with those with a morning chronotype. Total PedsQL scores also differed significantly across chronotype groups (p=0.007), with lower scores in the evening chronotype group. Social and school functioning subscale scores were significantly lower in participants with an evening chronotype. HbA 1c levels were positively correlated with age and diabetes duration, while total PedsQL scores showed a moderate negative correlation with age.

Conclusions

Chronotype was associated with both glycaemic control and quality of life in children and adolescents with type 1 diabetes. Evening chronotype was linked to higher HbA 1c levels and poorer psychosocial functioning, particularly in social and school domains. These findings suggest that circadian preferences may be relevant when interpreting metabolic and quality of life outcomes in paediatric type 1 diabetes.

More from our Archive